Join 250+ industry, academia and regulatory authorities who will share new ways of overcoming immunogenicity and bioassay challenges at 3 co-located conferences, 6 short courses, and 2 training seminars. Plus, a full day symposium on Bioassays for Immuno-Oncology. Please check back often for event updates. The final agendas will be posted soon.

If you are interested in speaking or sharing a recommended topic of discussion, please contact Nicole Lyscom, Ph.D. at nlyscom@healthtech.com.

To secure a sponsorship or exhibit package for 2017, contact Carolyn Benton at cbenton@healthtech.com.

2016 Event Stats:

• 250+ Delegates from 145 Companies
• 60 Speakers
• 25 Posters Presented
• 15 Countries Represented
• 14 Exhibiting Companies

View the 2016 Attendee List

Here’s what one of our delegate’s on-site said:

“CHI's Optimizing Bioassay for Biologics is one of the best bioassay venues in the biotech and biopharma industry. The conference provides very deep and broad scientific presentations, roundtable discussions, and excellent network opportunities for scientists, managers/directors, CROs, vendors and consultants.”
- Senior Group Leader, Bioassay Development, Hospira, a Pfizer Company

“Program and participants first class.”
- Associate Director, Novo Nordisk

“Breakout interaction with FDA experts was very valuable.”
- Associate Director, Alexion Pharmaceuticals Inc.

“Interesting new data and very relevant to the field.”
- Senior Scientist, Process Development, Amgen, Inc.

“Provided good overview of current problems and progress in the field.”
- Scientist, Bioanalytical Sciences, Immunogen

“Congratulations on a very well put together conference.”
- Assistant Vice President, Pfizer

View more testimonials